期刊文献+

FGFR1、FGFR3和Pokemon在膀胱癌中的表达及相关性研究 被引量:1

Study on Protein Expression and Clinical Correlations of FGFR1,FGFR3 and Pokemon in Bladder Cancer
原文传递
导出
摘要 目的通过观察FGFR1、FGFR3和Pokemon在膀胱癌组织的表达情况,探讨它们在膀胱癌发生、发展中的作用。方法采用免疫组化检测296例膀胱癌和48例正常膀胱组织中FGFR1、FGFR3和Pokemon蛋白的表达情况。结果 1)FGFR1在膀胱癌不同病理分期、分级及初发复发的表达率为:Ta-T1期7.5%,T2-T4期18.1%(p<0.01);低级别2.8%,低-高级别11.9%(p<0.05),高级别14.3%的(p<0.01);初发表达6.8%,复发表达率17.1%(p<0.01)。2)FGFR3在膀胱癌不同病理分期、分级的表达率为:Ta-T1期68.1%,T2-T4期35.0%(p<0.01));低级别75.0%,低-高级别60.3%(p<0.05),高级别44.9%(p<0.01)。3)Pokemon在膀胱癌不同病理分级及初发复发的表达率为:低级别47.2%,低-高级别66.7%(p<0.01),高级别80.6%(p<0.01);初发59.2%,复发80.0%(p<0.01)。结论 FGFR1在膀胱癌中的表达与病理分级、分期成正相关,复发表达明显高于初发;Pokemon在膀胱尿路上皮癌中的表达与病理分级成正相关,复发表达也明显高于初发,表明它们可能主要参与膀胱癌发展及转移等过程。FGFR3在膀胱癌中的表达与病理分级、分期成负相关,表明它可能在膀胱癌发展早期及低级别肿瘤发展中发挥着重要作用。 Objective By the study on protein expression of FGFR1 ,FGFR3 and Pokemon in bladder cancer,to identify their function in the development role of bladder cancer.Methods Immunohistochemistry was used to detect FGFR1 ,FGFR3 and Pokemon protein in 296 cases of bladder cancer and 48 cases of normal bladder tissue.Results 1 )FGFR1 bladder cancer in different pathological stage,grade and onset recurrent expression was:Ta-T1 7. 5%,T2-T4 1 8. 1% (p〈0. 01 );low level 2. 8%,low-high level 1 1 . 9% (p〈0. 05),high-level 1 4.3% (p〈0. 01 );early publication 6.8%,the recurrence expres-sion 1 7. 1% (p〈0. 01 ).2 )FGFR3 in various pathological staging of bladder cancer,grading expression was:Ta-T1 68. 1%,T2-T4 35. 0% (p〈0. 01 );low-level 75. 0% ,low-High level 60. 3% (p〈0. 05 ),high level 44. 9% (p〈0. 01 ).3.Pokemon in different pathological grading of bladder cancer recurrence and the onset of expression was:47. 2%low-level,low-High level 66. 7%(p〈0. 01 ),high-level 80. 6%(p〈0. 01 );initial issuance 59. 2%,relapse 80.0%(p〈0. 01 ).Conclusion FGFR1 expression and tumor grade in bladder cancer,staging a positive correlation,relapse was signifi-cantly higher than the initial issuance;Pokemon expression was positively correlated with tumor grade,recurrence expression was also significantly higher than the onset of bladder urothelial carcinoma,suggesting that they may be mainly involved in the process of developing bladder cancer and metastasis.FGFR3 expression and tumor grade,stage a negative correlation in bladder cancer,suggesting that it may develop in the early stage of bladder cancer and low-grade tumor development plays an important role.
出处 《世界科技研究与发展》 CSCD 2014年第6期664-667,共4页 World Sci-Tech R&D
基金 甘肃省卫生行业科研计划(GWGL2013-35) 甘肃省泌尿系疾病临床医学中心开放课题基金(MNLCZXKF-07)资助
关键词 膀胱癌 成纤维细胞生长因子受体1 成纤维细胞生长因子受体3 Pokemon蛋白 免疫组织化学 bladder cancer FGFR1 FGFR3 pokemon protein immunohistochemistry
  • 相关文献

参考文献18

  • 1ISA F, XIE L P, HU Z, et al. Dietary consumption and diet diversity and risk of developing bladder cancer: results from the South and East China case-control study[J]. Cancer Causes Control, 2013,24 ( 5 ) : 885 -895.
  • 2JACOBS B L,LEE C T,MONTIE J E. Bladder eancer ill 2010:how far have we come? [J]. A Caneer Journal for Clinicians. 2010,60 (4) :244-272.
  • 3GOEBELL P J, KNOWLES M A. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium[J]. Uro- logic Oncologie,2010,28(4) :409-428.
  • 4PASIN E, JOSEPHSON D Y, MITRA A P, et al. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history [J]. Reviews in Urology,2008,10 ( 1 ) : 31-43.
  • 5JEIAL A, SIEGEL R, XU J, et al. Cancer statistics, 2010 [J]. A Cancer Journal for Clinicians 2010,60 (5) :277-300.
  • 6TUMER N, GROSE R. Fibroblast growth factor signalling: from devel- opment to cancer [J]. Nature Reviews Cancer, 2010,10 ( 2 ) : 116- 129.
  • 7BASS A J, WATANABE H, MEMEL C H, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamus cell car- cinomas[J]. Nature Genetics,2009,41 ( 11 ) :1 238-1 242.
  • 8张炎,李庆霞.FGFR1在乳腺癌内分泌治疗中的研究进展[J].实用肿瘤杂志,2012,27(5):554-557. 被引量:2
  • 9DUTT A,RAMOS A H, HAMMEMAN P S, et al. InhibiLor-sensitive FGFR1 amplification in human non-small cell lung cancer[J]. PLoS One,2011,6(6) :e20351.
  • 10TOMLINSON D C,LAMONT F R,SHNYDER S D,et al. Fibroblast growth factor receptor 1 promotes proliferation and survival via acti- vation of the mitogen-activated protein kinase pathway in bladder cancer[J]. Cancer Researeh ,2009,69 (i 1 ) :4 613-4 620.

二级参考文献60

  • 1张水军,张弓,赵永福,李捷,屈清荣,李星.EphA2在原发性肝细胞癌中的表达及临床意义[J].中华实验外科杂志,2006,23(3):269-270. 被引量:8
  • 2计勇,何晓顺,马毅,朱晓峰,张韧,欧志英.Pokemon在肝细胞癌及癌旁、癌以远组织、肝硬化组织及正常肝组织中的表达[J].中华实验外科杂志,2007,24(2):187-189. 被引量:11
  • 3DOW JK, WHITE RW. Fibroblast growth factor-2: its structur e and property, paracrine function, tumor angiogenesis and prostate-related mitogenic and oncogenic functions[J]. Urology, 2000, 55(4): 800.
  • 4SASADA R, KUROKAWA T, IWANE M, et al. Transformation of mouse B ALB/c 3 T 3 cells with human basic fibroblast growth factor cDNA[J]. Mol Cell Biol, 1988, 8(3): 588.
  • 5OBRIEN T, CRANSTON D, FUGGLE S, et al. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer[J]. Cancer Re s, 1997, 57(1): 136.
  • 6JOUANNEAU J, PLOUET J, MOENS G, et al. FGF-2 and FGF-1 expres sed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo[J]. Oncogene, 1997, 14(6): 671.
  • 7ALLEN LE, MAHER PA. Expression of basic fibroblast growth factor an d its receptor in an invasive bladder carcinoma cell line[J]. J Cell Physiol, 1993, 155(2): 368.
  • 8DUROCHER Y, CHAPDELAINE A, CHEVALIER S. Tyrosine protein kinase act ivity of human hyperplastic prostate and carcinoma cell line PC 3 and Dul 45[J]. Cancer Res, 1989, 48(12): 4818.
  • 9Linos E, Spaons D, Rosner BA, et al. Effects of reproductive and demographic changes on breast cancer incidence in China:a modeling analysis[J]. J Natl Cancer Inst ,2008,100( 19 ) : 1352 - 1360.
  • 10Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:an overview of the randomized trials [ J]. Lancet, 2005,365 ( 9472 ) : 1687 - 1717.

共引文献14

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部